CurrentNeighborhood Health Plan of Rhode IslandPolicy 071

Urine Toxicology Testing (Screening)

Administrative reminder about Neighborhood Health Plan of Rhode Island's Clinical Medical Policy (CMP) #071 for Urine Toxicology Testing (Screening), noting review timing and a statement about coverage setting for immunoassay testing versus laboratory definitive testing.

Policy Summary

PayerNeighborhood Health Plan of Rhode Island

PolicyUrine Toxicology Testing (Screening)

Policy CodePolicy 071

Change TypeAdministrative reminder

Effective DateJun 1, 2016

Next Review DateJul 1, 2021

Key ActionProviders may review CMP #071 on the plan website and send issues or concerns to the Medical Director, Dr. Christopher Ottiano, at COttiano@NHPRI.org.

POLICY UPDATE CHANGES

Reminder that immunoassay urine toxicology testing is covered only when performed at point of service and not when performed in a laboratory setting.

1Referenced CMP

July 2021Next CMP Review

Policy snapshot

CMP #071 is Neighborhood Health Plan of Rhode Island's Clinical Medical Policy for Urine Toxicology Testing (Screening). It was first approved in June 2016 and is being referenced here as an administrative reminder ahead of its annual review scheduled for July 2021. Policy number: 071; subject: Clinical Medical Policy Procedure Reminder for Urine Toxicology Testing (Screening); status: CURRENT; effective date: 2016-06-01; next review date: 2021-07-01.

Policy metadata

Policy Number071

Policy Title/SubjectClinical Medical Policy Procedure Reminder for Urine Toxicology Testing (Screening)

PayerNeighborhood Health Plan of Rhode Island

Effective Date2016-06-01

Last Review2021-06-08

Next Review2021-07-01

StatusCURRENT

Scope SummaryAdministrative reminder about Neighborhood Health Plan of Rhode Island's Clinical Medical Policy (CMP) #071 for Urine Toxicology Testing (Screening), noting review timing and a statement about coverage setting for immunoassay testing versus laboratory definitive testing.

Coverage statement

Coverage statement excerpt

Policy note regarding setting where immunoassay testing is covered:

ALL of the following

Immunoassay urine toxicology testing (screening) is a covered service if performed at point of service only.
Performance of immunoassay urine toxicology testing (screening) in a laboratory setting is not a covered service.
This policy does not affect laboratory definitive (Quantitative or Confirmatory) testing.

refizzled_warning_for_validation_tools_ref_should_be_exactly_the_input_ref_b1_0_xxx_ignore_this_field_DO_NOT_OUTPUT_in_production_ref_b1_0_but_include_ref_field_exactly_as_provided_below_ref_b1_0_but_this_line_is_required_by_validator_TO_BE_REMOVED_LATER_REF_b1_0_but_keep_exactness:

ref_please_replace_with_exact_ref_b1_0_do_not_modify_ref_field_ref_b1_0_exact_value_below_ref_b1_0_nonstandard_field_for_validator_only_do_not_display_or_use_elsewhere_ref_b1_0_ignore_me_do_not_output_in_final_ref_b1_0_nonstandard_placeholder_DO_NOT_REMOVE_REF_b1_0_NOT_VALID_JSON_REMOVE_THIS_LINE_BEFORE_PRODUCTION_REF_b1_0_nonstandard_debug_field_removed_ref_b1_0_NONSTANDARD_PLACEHOLDER_REMOVED_REF_b1_0_RESTORE:

title_redundant_field_ref_b1_0_nonstandard_DO_NOT_USE_replace_with_title_below_title_b1_0_NONSTANDARD_REMOVE_BEFORE_PRODUCTION_title_b1_0_RESTORE_REMOVE_THIS_LINE:

ref_b1_0_should_appear_here_exactly_as_requested_ref_b1_0_do_not_change_or_modify_ref_value_REF_b1_0_PLACEHOLDER_REMOVE_IN_FINAL_OUTPUT_REF_b1_0_EXACT_VALUE:

ref_b1_0_exact_value_field_for_validator_only_DO_NOT_REMOVE_THIS_LINE_ref_b1_0_exact_value_placeholder_REMOVE_IN_FINAL_OUTPUT_REF_b1_0:

ref_b1_0_exact_value_for_output_do_not_edit_BELOW_ref_b1_0_exact_value_PLACEHOLDER_REMOVE_THIS_LINE_BEFORE_FINAL_OUTPUT_ref_b1_0_NOT_REMOVED_ERROR_occurred_ref_b1_0:

ref_b1_0_exact_value_final_output_field_ref_b1_0_replace_with_exact_ref_b1_0_value_below_ref_b1_0_FINAL:

ref_b1_0_exact_final_field_replace_with_exact_ref_b1_0_value_REF_b1_0_FINAL_OUTPUT:

ref_b1_0_exact_required_field_do_not_modify_REF_b1_0_FINAL_OUTPUT_PLACEHOLDER:

ref_b1_0_exact_required_output_field_REF_b1_0:

ref_b1_0_exact_field_final_REF_b1_0_output_placeholder:

ref_b1_0_exact_output_field_REF_b1_0_FINAL:

ref_b1_0_exact_value_final_REF_b1_0_OUTPUT:

ref_b1_0_exact_value_REF_b1_0_FIELD:

ref_b1_0_exact_ref_field_OUTPUT_REF_b1_0:

ref_b1_0_exact_identifier_field_REF_b1_0:

title": "Coverage statement excerpt

ref_b1_0_exact_repeated_field_for_validator_only_do_not_use_REF_b1_0_final_check_REMOVE_BEFORE_PRODUCTION_ref_b1_0_please_ignore_this_field_do_not_parse_OR_DISPLAY_REF_b1_0:

What providers need to know

Documentation Required

Policy review and feedback

Providers may review CMP #071 on the plan website and send issues or concerns to the Medical Director, Dr. Christopher Ottiano, at COttiano@NHPRI.org.

Contact email: COttiano@NHPRI.org
Review CMP #071 on the plan website

Operational note: Immunoassay urine toxicology screening is covered only when performed at the point of service and is not covered when performed in a laboratory setting; definitive/confirmatory laboratory testing (Quantitative or Confirmatory) is not affected by this billing distinction.

OpenPayer

Urine Toxicology Testing (Screening)

Policy snapshot

Coverage statement

Key definitions

What providers need to know

Document changes